Animal Models of Serotonergic Psychedelics

被引:103
|
作者
Hanks, James B. [1 ]
Gonzalez-Maeso, Javier [1 ,2 ,3 ]
机构
[1] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA
[2] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA
[3] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY 10029 USA
来源
ACS CHEMICAL NEUROSCIENCE | 2013年 / 4卷 / 01期
关键词
Psychedelic; hallucinogenic; schizophrenia; psychosis; serotonin 5-HT2A receptor; G protein-coupled receptor (GPCR); lysergic acid diethylamide (LSD); mouse behavior models; LYSERGIC-ACID DIETHYLAMIDE; DISCRIMINATIVE STIMULUS PROPERTIES; 5-HT2A RECEPTOR AGONISTS; BETA-ADRENERGIC-RECEPTOR; ANTAGONIST SR 141716A; HEAD-TWITCH RESPONSE; REACTION-TIME-TASK; PLUS-MAZE TEST; PREPULSE INHIBITION; HALLUCINOGENIC DRUGS;
D O I
10.1021/cn300138m
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The serotonin 5-HT2A receptor is the major target of psychedelic drugs such as lysergic acid diethylamide (LSD), mescaline, and psilocybin. Serotonergic psychedelics induce profound effects on cognition, emotion, and sensory processing that often seem uniquely human. This raises questions about the validity of animal models of psychedelic drug action. Nonetheless, recent findings suggest behavioral abnormalities elicited by psychedelics in rodents that predict such effects in humans. Here we review the behavioral effects induced by psychedelic drugs in rodent models, discuss the translational potential of these findings, and define areas where further research is needed to better understand the molecular mechanisms and neuronal circuits underlying their neuropsychological effects.
引用
收藏
页码:33 / 42
页数:10
相关论文
共 50 条
  • [1] Serotonin toxicity of serotonergic psychedelics
    Benjamin Malcolm
    Kelan Thomas
    [J]. Psychopharmacology, 2022, 239 : 1881 - 1891
  • [2] Serotonergic Psychedelics in Neural Plasticity
    Lukasiewicz, Kacper
    Baker, Jacob J.
    Zuo, Yi
    Lu, Ju
    [J]. FRONTIERS IN MOLECULAR NEUROSCIENCE, 2021, 14
  • [3] Serotonin toxicity of serotonergic psychedelics
    Malcolm, Benjamin
    Thomas, Kelan
    [J]. PSYCHOPHARMACOLOGY, 2022, 239 (06) : 1881 - 1891
  • [4] Abnormalities of serotonergic neurotransmission in animal models of SUDEP
    Feng, Hua-Jun
    Faingold, Carl L.
    [J]. EPILEPSY & BEHAVIOR, 2017, 71 : 174 - 180
  • [5] Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives
    Pallavicini, Carla
    Vilas, Martina G.
    Villarreal, Mirta
    Zamberlan, Federico
    Muthukumaraswamy, Suresh
    Nutt, David
    Carhart-Harris, Robin
    Tagliazucchi, Enzo
    [J]. NEUROIMAGE, 2019, 200 : 281 - 291
  • [6] Multimodal Neuroimaging of the Effect of Serotonergic Psychedelics on the Brain
    Frautschi, Paloma C.
    Singh, Ajay P.
    Stowe, Nicholas A.
    Yu, John-Paul J.
    [J]. AMERICAN JOURNAL OF NEURORADIOLOGY, 2024,
  • [7] Motives for the use of serotonergic psychedelics: A systematic review
    Basedow, Lukas A.
    Kuitunen-Paul, Soren
    [J]. DRUG AND ALCOHOL REVIEW, 2022, 41 (06) : 1391 - 1403
  • [8] Efficacy of psychedelics in animal models of binge drinking and alcohol use disorder
    Jeanblanc, J.
    Bordy, R.
    Meinhardt, M.
    Spanagel, R.
    Ciccocioppo, R.
    Naassila, M.
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 46 : 64 - 64
  • [9] ANIMAL-MODELS FOR ANXIETY AND RESPONSE TO SEROTONERGIC DRUGS
    BROEKKAMP, CLE
    BERENDSEN, HHG
    JENCK, F
    VANDELFT, AML
    [J]. PSYCHOPATHOLOGY, 1989, 22 : 2 - 12
  • [10] ROLE OF SEROTONERGIC MECHANISMS IN ANIMAL-MODELS OF PREDATION
    KATZ, RJ
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY, 1980, 4 (03): : 219 - 231